Peptide Therapeutics Foundation
Donations deductiblePeptide Therapeutics Foundation's network
3 peoplei3 people on this map.The large node is the subject of this page. Solid lines are what the register itself records (3). Form 990 filings give names without a person identifier; SEC insider filings carry a CIK.The board
3 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations.Time served and departures are observed across annual filings. Observed time served is a lower bound - a member may have joined before the first year on record.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Phil Dawson PHD Chair | Chairman of Board | 2023 | 3 yrs |
| Adam Mezo PHD | President | 2023 | 3 yrs |
| Nick COX PHD (also filed as Nick Cox PHD) | Company secretary | 2023 | 3 yrs |
Under 5 years5 to 6 years6 years or more
Officers and senior leadership
4 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Andrew Parker | SVP & Chief | 2018 |
| Adrienne DAy PH D | Treasurer & Board Administrator | 2024 |
| RIE Schultz Hansen PHD | SVP & Chief | since 2019 |
| Yvonne Angell | Director of | 2018 |
Pay and hours
year to 31 December 2025iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Phil Dawson PhD | Chairman of Board | 1 | $0 | ||
| Adam Mezo PhD | President | 1 | $0 | ||
| Bryan Fuchs PhD | Secretary | 1 | $0 | ||
| Adrienne Day PhD | Treasurer and Board Administrator | 1 | $0 |
No pay was reported for anyone in Part VII on this return.
About
- Legal name
- Peptide Therapeutics Foundation
- EIN
- 263728931
- Address
- 9395 Cabot Dr, San Diego, CA, 92126-4310
- State
- California
- Mission
- The mission of Peptide Therapeutics Foundation is to provide and promote public and charitable educational and information programs, materials, research and discussion in the the medical scientific field of peptide science and technology (as filed on the Form 990)
- Activity (NTEE)
- H05 Medical research
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Medical Research
- Size band
- 4 (IRS master file code)
- Formed
- 2008
- Principal officer
- Adrienne Day PHD (as named on the Form 990)
- IRS ruling date
- 1 August 2012
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 6, latest 2024
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥3years on the filingsPhil Dawson PHD
≥3years on the filingsAdam Mezo PHD
≥3years on the filingsNick COX PHD
Latest return
year to 31 December 2025iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2025. US dollars, as filed.- Total assets
- $405k
- Total liabilities
- $0
- Net assets or fund balances
- $405k
- Contributions and grants received
- $100k
- Program service revenue
- $110k
- Employees
- 0
- Volunteers
- 5
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $174k | $145k | $30k |
As filed on the IRS Form 990. US dollars.